Several studies suggest, but do not prove directly, that muscarinic recepto
rs may be able to form dimeric or oligomeric arrays. To address this issue
in a more direct fashion, we designed a series of biochemical experiments u
sing a modified version of the rat m3 muscarinic receptor (referred to as m
3') as a model system. When membrane lysates prepared from m3' receptor-exp
ressing COS-7 cells were subjected to Western blot analysis under non-reduc
ing conditions, several immunoreactive species were observed corresponding
in size to putative receptor monomers, dimers, and oligomers, However, unde
r reducing conditions, the monomeric receptor species represented the only
detectable immunoreactive protein, consistent with the presence of disulfid
e-linked m3 receptor complexes. Similar results were obtained when native m
3 muscarinic receptors present in rat brain membranes were analyzed. Contro
l experiments carried out in the presence of high concentrations of the SH
group alkylating agent, N-ethylmaleimide, suggested that disulfide bond for
mation did not occur artifactually during the preparation of cell lysates,
The formation of m3' receptor dimers/multimers was confirmed in coimmunopre
cipitation studies using differentially epitope-tagged m3' receptor constru
cts. In addition, these studies showed that m3' receptors were also able to
form non-covalently associated receptor dimers and that m3' receptor dimer
formation was receptor subtype-specific, Immunological studies also demons
trated that m3' receptor dimers/multimers were abundantly expressed on the
cell surface. Site-directed mutagenesis studies indicated that two conserve
d extracellular Cys residues (Cys-140 and Cys-220) play key roles in the fo
rmation of disulfide-linked m3' receptor dimers. These results provide the
first direct evidence for the existence of muscarinic receptor dimers and h
ighlight the specificity and molecular diversity of G protein-coupled recep
tor dimerization/oligomerization.